Merck, Schering Settle Investor Action Over Merger
Pharmaceutical giants Merck & Co. Inc. and Schering-Plough Co. have reached a settlement with shareholders to end a consolidated class action over their planned $46.3 billion merger, the companies announced Friday....To view the full article, register now.
Already a subscriber? Click here to view full article